Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Angle Plc ADR
(OP:
ANPCY
)
0.9912
UNCHANGED
Last Price
Updated: 1:07 PM EDT, Apr 9, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Angle Plc ADR
< Previous
1
2
3
4
5
Next >
Angle PLC Announces Holding(s) in Company
January 10, 2023
Via
ACCESSWIRE
Angle plc Announces Appointment of Non-Executive Director
January 05, 2023
Via
ACCESSWIRE
Angle plc Announces Business Update
January 05, 2023
Via
ACCESSWIRE
Angle PLC Announces Two Parsortix Posters Presented at SABCS
December 12, 2022
Via
ACCESSWIRE
Angle PLC Announces Issue of Equity
December 02, 2022
Via
ACCESSWIRE
Angle PLC Announces Multiple Downstream Analysis Techniques for CTCs
November 02, 2022
Via
ACCESSWIRE
Angle PLC Announces Parsortix Poster Presented at ISLB Meeting
October 24, 2022
Via
ACCESSWIRE
Angle PLC Announces Issue of Equity
October 21, 2022
Via
ACCESSWIRE
Angle PLC Announces Streamlining of Operations to Increase Cash Runway
October 18, 2022
Via
ACCESSWIRE
Angle PLC announces TR-1: Notification of major holdings
October 17, 2022
Via
ACCESSWIRE
Angle PLC Announces First Regional Distribution Agreement
October 12, 2022
Via
ACCESSWIRE
Angle PLC Announces Holding(s) in Company
September 30, 2022
Via
ACCESSWIRE
Angle PLC Announces Issue of Equity
September 30, 2022
Via
ACCESSWIRE
Angle PLC Announces Interim Results
September 29, 2022
Via
ACCESSWIRE
Angle PLC Announces Positive Headline Results From Ovarian Study
September 29, 2022
Via
ACCESSWIRE
Angle PLC announces Study using Parsortix in head and neck cancer
September 28, 2022
Via
ACCESSWIRE
Angle PLC Announces New Poster Presented at ASCP Meeting
September 13, 2022
Via
ACCESSWIRE
Angle PLC Announces Novel Assay; Predicts Malignancy in Pelvic Mass
September 12, 2022
Via
ACCESSWIRE
Angle PLC Announces Notice of Interim Results and Webcast
September 01, 2022
Via
ACCESSWIRE
Angle PLC Announces Issue of Equity
July 08, 2022
Exercise of Options and Total Voting Rights
From
ANGLE plc
Via
AccessWire
Angle PLC Announces Result of 2022 Annual General Meeting
June 29, 2022
GUILDFORD, SURREY / ACCESSWIRE / June 29, 2022 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, announces that at the Annual General Meeting of the Company held earlier today,...
From
ANGLE plc
Via
AccessWire
Angle PLC Announces Spread of Breast Cancer Accelerates During Sleep
June 27, 2022
BREAKTHROUGH RESEARCH WITH PARSORTIX REVEALS SPREAD OF BREAST CANCER ACCELERATES DURING SLEEP
From
ANGLE plc
Via
AccessWire
Angle PLC Announces Issue of Equity
June 23, 2022
Exercise of Options and Total Voting Rights
From
ANGLE plc
Via
AccessWire
Angle PLC Announces Secured Contract From Pharma Services Customer
June 22, 2022
Additional contract for a new clinical trial
From
ANGLE plc
Via
AccessWire
Angle PLC Announces Predicting Immunotherapy Response in SCLC
June 16, 2022
PARSORTIX SYSTEM DEMONSTRATES POTENTIAL IN PREDICTING IMMUNOTHERAPY RESPONSE IN SMALL CELL LUNG CANCER
From
ANGLE plc
Via
AccessWire
Angle PLC Announces Potential Role of Invasive Cellular Protrusions
June 14, 2022
Prostate cancer cells may use invasive cellular protrusions to aid entry into the blood stream, a potential target in the metastatic process for novel therapy development
From
ANGLE plc
Via
AccessWire
Angle PLC Announces Partnership with Major United States Urology Group
May 30, 2022
PARTNERSHIP ESTABLISHED WITH A MAJOR UNITED STATES UROLOGY GROUP TO CONDUCT CLINICAL STUDIES IN PROSTATE CANCER AND AS A POTENTIAL ROUTE TO MARKET
From
ANGLE plc
Via
AccessWire
Angle PLC Announces Molecular Characterisation of CTCs
May 27, 2022
Parsortix system harvests intact CTCs for single-cell whole genomic sequencing from frozen and fresh blood samples with the same efficiency
From
ANGLE plc
Via
AccessWire
ANGLE receives FDA clearance for Parsortix
May 25, 2022
ANGLE ACHIEVES WORLD FIRST WITH FDA CLEARANCE FOR ITS PARSORTIX SYSTEMFDA De Novo product clearance to harvest cancer cells from blood for subsequent analysis offers the prospect of a new era of...
From
ANGLE plc
Via
AccessWire
Exposures
Product Safety
Angle PLC - Prostate Cancer UK Funds New Study Using Parsortix
May 20, 2022
Research Into the Use of Parsortix-Based CTC Blood Test To Assess Whether Prostate Cancer Patients Require Prostatectomy SurgeryPotential for a New Standard of Care in an Area of High Unmet Medical...
From
ANGLE plc
Via
AccessWire
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.